12259-1-AP
antibody from Proteintech Group
Targeting: SERPING1
C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12259-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12259-1-AP, RRID:AB_2285663
- Product name
- SERPING1/C1 Inactivator antibody
- Antibody type
- Polyclonal
- Description
- SERPING1/C1 Inactivator antibody (Cat. #12259-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.
Chronic Cerebral Hypoperfusion Activates the Coagulation and Complement Cascades in Alzheimer's Disease Mice.
Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.
The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII: reply.
Abe K, Shang J, Shi X, Yamashita T, Hishikawa N, Takemoto M, Morihara R, Nakano Y, Ohta Y, Deguchi K, Ikeda M, Ikeda Y, Okamoto K, Shoji M, Takatama M, Kojo M, Kuroda T, Ono K, Kimura N, Matsubara E, Osakada Y, Wakutani Y, Takao Y, Higashi Y, Asada K, Senga T, Lee LJ, Tanaka K
Journal of Alzheimer's disease : JAD 2020;73(1):217-227
Journal of Alzheimer's disease : JAD 2020;73(1):217-227
Chronic Cerebral Hypoperfusion Activates the Coagulation and Complement Cascades in Alzheimer's Disease Mice.
Shi X, Ohta Y, Liu X, Shang J, Morihara R, Nakano Y, Feng T, Huang Y, Sato K, Takemoto M, Hishikawa N, Yamashita T, Abe K
Neuroscience 2019 Sep 15;416:126-136
Neuroscience 2019 Sep 15;416:126-136
Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S, Du T, Wu W, Chen X, Lai Y, Zhu D, Wang Q, Ma X, Lin C, Li Z, Guo Z, Huang H
Urologic oncology 2018 Aug;36(8):366.e1-366.e9
Urologic oncology 2018 Aug;36(8):366.e1-366.e9
The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.
Zamolodchikov D, Renné T, Strickland S
Journal of thrombosis and haemostasis : JTH 2016 May;14(5):995-1007
Journal of thrombosis and haemostasis : JTH 2016 May;14(5):995-1007
The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII: reply.
Zamolodchikov D, Strickland S
Journal of thrombosis and haemostasis : JTH 2016 Jul;14(7):1489
Journal of thrombosis and haemostasis : JTH 2016 Jul;14(7):1489
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The SERPING1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human SERPING1. This antibody recognizes human, mouse, rat antigen. The SERPING1 antibody has been validated for the following applications: ELISA, WB analysis.